We performed insertional mutagenesis screens in p53−/−, p19ARF−/− and wild-type mice to identify genes that collaborate with loss of either p53 or p19ARF in tumorigenesis and in doing so gained new insight in the functional differences between these tumor suppressors. The gene discussed is TP53; the disease is neoplasm.